BioSpace News Archive

NOXXON Pharma N.V., a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment, announces the results of its rights issue for a limited amount of € 521 K.

Turku, Finland, July 19th 2019: Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women’s health, announces that Sunstone Life Science Ventures has made a €5 million investment in Forendo.

In Cerebrospinal Fluid and the Identification of a Target Engagement Biomarker for the New Anti-Tau Antibody E2814 at Alzheimer’s Association International Conference (AAIC) 2019

Eisai Co., Ltd. announced the presentation and discussion about the treatment, including oral beta amyloid cleaving enzyme (BACE) inhibitor elenbecestat(1) research data on Alzheimer’s disease(AD), were given in the AAIC’s Focused Topic Session “Discussion of BACEi Trial Findings: Challenges and Opportunities” at the Alzheimer’s Association International Conference (AAIC) held in Los Angeles, California, United States, from July 14 to 18, 2019.

Sensyne Health plc, the British clinical AI technology company, today welcomes EY Global Services Limited’s report entitled Realising the Value of Healthcare Data.

Ascentage Pharma, announced that the company was notified by the U.S. Food & Drug Administration on the clearance of the Investigational New Drug application which allows the company to initiate its Phase Ib clinical trial of HQP1351, a novel drug candidate developed by Ascentage Pharma, for the treatment of patients with tyrosine kinase inhibitors-resistant chronic myeloid leukemia in the United States.

PACT’s gene-edited T cells were observed to kill tumor cells by targeting patient-specific tumor mutation targets in non-clinical testing

Friday, Judge Richard J. Leon of the U.S. District Court for the District of Columbia heard closing arguments from attorneys for the parties and also from several friends of the court (amicus curiae) opposed to the nearly $70 billion acquisition of Aetna by CVS Health.

In light of a worrisome funding update and the recent release of the 2018 global HIV/AIDS statistics by the Joint United Nations Programme on HIV/AIDS, AIDS Healthcare Foundation is sounding the alarm on the crisis by calling for increased data accuracy measures and an urgent recommitment to fully funding the Global Fund to Fight AIDS, Tuberculosis and Malaria.